Delcath Systems (DCTH)

Healthcare · Medical Devices
$15.36 +2.13% on the day Market cap $506M 52-week range $8.12 to $17.42 Prices as of Oct 11, 2026

What the price implies

A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.

Free cash flow growth the price needs
7% a year for 10 years

At a market value of $506M, Delcath Systems's free cash flow of $21M (fiscal 2025) would need to grow about 7% a year for the stock to be worth today's price.

Assumes a 9% discount rate and 3% growth after year 10, on free cash flow (operating cash flow minus capital spending) from Delcath Systems's SEC filings. Change any assumption, or model revenue and margins instead, in the Modeling tab, or try your own numbers in the reverse DCF calculator.

Implied by the price7.4% a year
Free cash flow, last – years—
Revenue, same period51.8% a year
Price to free cash flow24.1x

Fundamental grade

C

Five factors scored 1 to 9 from DCTH's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.

Valuation4
Profitability4
Growth4
Financial health9
Cash efficiency9

Results from SEC filings

Fiscal years, from Delcath Systems's 10-K filings. Ten years of the full income statement, balance sheet and cash flow.

Fiscal year20212022202320242025
Revenue$4M$3M$2M$37M$85M
Net income-$26M-$37M-$48M-$26M$3M
Free cash flow-$23M-$25M-$31M-$19M$21M
EPS (diluted)-$3.59-$4.12-$2.94-$0.93$0.07
Operating margin-690.0%-1245.1%-1849.0%-33.4%0.77%

Where the revenue comes from

Revenue by products, fiscal 2025. Every breakdown, year by year.

HEPZATO KIT$79M92%
CHEMOSAT$6M8%

Superinvestors who own DCTH

From each investor's latest 13F filing (what a 13F shows). 1 of the investors we track hold it.

InvestorLast quarterValue% of portfolioQuarter
Cliff Asness
AQR Capital Management
Added $2M0.00%Q2 2026

Insider buying

Open-market purchases by Delcath Systems's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.

DateInsiderSharesPriceValue
Nov 11, 2025 Gerard J Michel
11,500$8.53$98,095

Get an alert at your buy price

Pick the price you'd be interested at. We'll email you when DCTH trades at or below it.

$

New accounts get 7 days of Pro, price alerts included. No card needed.

In the full deep dive

DCF fair value per share
Yearly return (IRR) at today's price
Growth implied by revenue and margins
15+ years of statements and quarters

Questions

What growth does Delcath Systems's stock price imply?

At a market value of $506M, Delcath Systems would need its free cash flow to grow about 7% a year for 10 years (discounted at 9%, 3% growth after that) to be worth today's price.

Are Delcath Systems insiders buying the stock?

1 open-market insider purchase of DCTH in the last 12 months, from SEC Form 4 filings.

Which superinvestors own Delcath Systems?

1 of the superinvestors Investingly tracks hold DCTH in their latest 13F, including Cliff Asness.

Prices and ratios as of Oct 11, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.